Targets for Combating the Evolution of Acquired Antibiotic
Resistance

Culyba, Matthew
J.; Mo, Charlie Y.; Kohli, Rahul M.

doi:10.1021/acs.biochem.5b00109

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Targets for Combating the Evolution of Acquired Antibiotic Resistance

Published Date:

Jun 05 2015

Publisher's site:

http://dx.doi.org/10.1021/acs.biochem.5b00109 New Site Icon

Source:

Biochemistry. 2015; 54(23):3573-3582.

[PDF-3.43 MB]

Details:

Personal Authors:

Culyba, Matthew J. ; Mo, Charlie Y. ; Kohli, Rahul M. ;

Keywords:

[+]

Pubmed ID:

26016604

Pubmed Central ID:

PMC4471857

Description:

Bacteria possess a remarkable ability to rapidly adapt and evolve in response to antibiotics. Acquired antibiotic resistance can arise by multiple mechanisms but commonly involves altering the target site of the drug, enzymatically inactivating the drug, or preventing the drug from accessing its target. These mechanisms involve new genetic changes in the pathogen leading to heritable resistance. This recognition underscores the importance of understanding how such genetic changes can arise. Here, we review recent advances in our understanding of the processes that contribute to the evolution of antibiotic resistance, with a particular focus on hypermutation mediated by the SOS pathway and horizontal gene transfer. We explore the molecular mechanisms involved in acquired resistance and discuss their viability as potential targets. We propose that additional studies into these adaptive mechanisms not only can provide insights into evolution but also can offer a strategy for potentiating our current antibiotic arsenal.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Funding:

DP2-GM105444/DP/NCCDPHP CDC HHS/United States
T32 AR007442/AR/NIAMS NIH HHS/United States
T32 GM7229/GM/NIGMS NIH HHS/United States

Main Document Checksum:

[+]

Supporting Files:

	bi-2015-001092_0006.gif	image/gif
	bi-2015-001092_0006.jpg	image/jpeg
	bi-2015-001092_0007.gif	image/gif
	bi-2015-001092_0007.jpg	image/jpeg
	bi5b00109.nxml	text/plain
	license.txt	text/plain
	bi-2015-001092_0001.gif	image/gif
	bi-2015-001092_0001.jpg	image/jpeg
	bi-2015-001092_0003.gif	image/gif
	bi-2015-001092_0003.jpg	image/jpeg
	bi-2015-001092_0004.gif	image/gif
	bi-2015-001092_0004.jpg	image/jpeg
	bi-2015-001092_0005.gif	image/gif
	bi-2015-001092_0005.jpg	image/jpeg

No Related Documents.

You May Also Like:

Record of the proceedings : Healthcare Infection Control Practices Advisory Committee, July 14-15, 2016

Corporate Author:

Healthcare Infection Control Practices Advisory Committee (U.S.). National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion..

Published:

3/6/17

Description:

Publication date from document properties : 2016-July-HICPAC-meeting.pdf

File Type:

[PDF - 1.13 MB]
Specificity Determinants for Autoproteolysis of LexA, a Key Regulator of Bacterial SOS Mutagenesis

Personal Author:

Mo, Charlie Y.; Birdwell, L. Dillon; Kohli, Rahul M.;

Published:

May 08 2014

Source:

Biochemistry. 2014; 53(19):3158-3168.

Description:

Bacteria utilize the tightly regulated stress response (SOS) pathway to respond to a variety of genotoxic agents, including antimicrobials. Activation of the SOS response is regulated by a key repressor-protease, LexA, which undergoes autoproteolysis...

File Type:

[PDF - 4.69 MB]
DBD bulletin ; issue 16, summer 2015

Corporate Author:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases.

Published:

summer 2015

Series:

DBD bulletin ; issue 16

Description:

dbd-bulletin-summer2015.pdf

File Type:

[PDF - 4.51 MB]
Inventory of projects : Progress report: Implementation of A Public Health Action Plan To Combat Antimicrobial Resistance : progress through 2008

Corporate Author:

United States. Interagency Task Force on Antimicrobial Resistance.

Published:

December 29, 2009

Description:

Last revised: December 29, 2009

File Type:

[PDF - 1.11 MB]
National Action Plan for Combating Multidrug-Resistant Tuberculosis : year two report May 2018

Corporate Author:

United States. Agency for International Development.. National Institute of Allergy and Infectious Diseases (U.S.). Centers for Disease Control and Prevention (U.S.).

Published:

May 2018

Description:

NAP-MDR-TB-Year-Two-508.pdf

File Type:

[PDF - 617.78 KB]